Chemoinformaics analysis of 1,2,4-Trimethylbenzene
| Molecular Weight | 120.195 | nRot | 0 |
| Heavy Atom Molecular Weight | 108.099 | nRig | 11 |
| Exact Molecular Weight | 120.094 | nRing | 1 |
| Solubility: LogS | -3.106 | nHRing | 0 |
| Solubility: LogP | 3.36 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 23.0315 |
| nHD | 0 | BPOL | 12.0385 |
| QED | 0.815 |
| Synth | 2.425 |
| Natural Product Likeliness | -0.34 |
| NR-PPAR-gamma | 0.107 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.003 |
| HIA | 0.003 |
| CACO-2 | -4.563 |
| MDCK | 0.0000123 |
| BBB | 0.949 |
| PPB | 0.96622 |
| VDSS | 1.132 |
| FU | 0.0439977 |
| CYP1A2-inh | 0.987 |
| CYP1A2-sub | 0.58 |
| CYP2c19-inh | 0.946 |
| CYP2c19-sub | 0.136 |
| CYP2c9-inh | 0.835 |
| CYP2c9-sub | 0.871 |
| CYP2d6-inh | 0.921 |
| CYP2d6-sub | 0.324 |
| CYP3a4-inh | 0.881 |
| CYP3a4-sub | 0.304 |
| CL | 3.039 |
| T12 | 0.39 |
| hERG | 0.016 |
| Ames | 0.381 |
| ROA | 0.189 |
| SkinSen | 0.105 |
| Carcinogencity | 0.584 |
| EI | 0.91 |
| Respiratory | 0.966 |
| NR-Aromatase | 0.253 |
| Antiviral | No |
| Prediction | 0.926613 |